INSIGHTS ON CLINICAL TRIAL DESIGN
-
![GettyImages-1251666666 team of dcotors clinical]( "Control And Transparency: Solving Sponsors' Key Challenges In Study Launch")
Control And Transparency: Solving Sponsors' Key Challenges In Study LaunchLearn how SaaS technology can revolutionize clinical trial launches by improving transparency, increasing control, and streamlining efficiency.
-
![GettyImages-1457289257 patient]( "Quantitative ROI With DCTs")
Quantitative ROI With DCTsThrough dedicated staffing, operational oversight, and collaboration with site teams, see how we were able to transform a struggling cardiology study into a revitalized recruitment effort.
-
![Digital Eye-GettyImages-2184122570]( "When Your Protocol Includes Ocular Endpoints")
When Your Protocol Includes Ocular EndpointsStandardizing ocular endpoint execution reduces participant dropout and eliminates data variability. Specialized oversight secures clinical timelines and ensures high-quality, submission-ready data.
-
![Clinical Leader Solutions Expo]( "Make Trial Participation Easier With An Innovative Technology Platform")
Make Trial Participation Easier With An Innovative Technology PlatformExplore an impactful, innovative solution aimed at making patient participation in clinical trials easier.
-
Advancing Clinical Research In 2025: Meeting FDA Standards In DCT1/22/2025
Explore the key components of new FDA guidance on DCTs, including a focus on participant-centric designs and the use of Mobile Research Units (MRUs) to overcome geographic and technological barriers.
-
Stop Guessing On Trial Feasibility: Simulating Patient Recruitment With AI5/28/2026
Simulate enrollment, endpoints, and criteria with integrated data and synthetic populations to test protocol feasibility early — refining design and reducing recruitment and regulatory risks.
-
Reduction Of Screen Failures In A Biomarker2/24/2026
Targeted prescreening for biomarker and cognitive criteria cut screen failures in a complex Alzheimer’s trial, speeding enrollment and improving site efficiency while maintaining strict eligibility.
-
Market Approval For A Novel Non-Hodgkin Lymphoma (NHL) Therapy4/11/2025
Explore a collaboration that underscores the importance of strategic planning and regulatory engagement in the approval process.
-
Master Protocols: Implementing Effective Treatment Adaptations8/25/2025
From balancing treatment ratios and managing eligibility to accommodating site-specific readiness and protocol amendments, a well-designed IRT system enables seamless transitions.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![Clinicians doctors meeting iStock-1264556832]( "Think Bold. Think Scientific. Think Veristat.")
Veristat harnesses knowledge, expertise, and scale to provide superior solutions and progressive approaches to mitigate risks and achieve meaningful outcomes for biopharmaceutical and medical technology companies, and their patients.
-
![GettyImages-1220710526 lab, research]( "Clinical Research Consulting Services, Simplified")
Expert Support for Clinical Research and Research Administration
-
![GettyImages-2176126405-digital-puzzle]( "First-In-Human To Proof-Of-Concept: The DVCR Continuity Model")
With a single, consistent team from FIH to Proof-of-Concept, this Continuity Model eliminates fragmented handoffs to keep program knowledge intact and speed your path to Phase II.
-
![board meeting]( "IRB Review Services For Phase I Research")
With experience overseeing thousands of Phase I studies in the US and Canada, Advarra’s institutional review board (IRB) understands the unique requirements of Phase I study design and conduct. Our dedicated team and processes are built to support your Phase I research needs.
-
![GettyImages-638646884 medical team meeting]( "Rethinking Lab Logistics: Delivering The Complex Without Compromise")
Through Home Trial Support (HTS), it is possible to carry out even the most demanding sampling protocols safely, consistently, and at scale—bringing collection and processing directly to patients.
